NCT06355349View on ClinicalTrials.gov

To Evaluate the Safety and PK Characteristics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

April 28, 2023

Primary Completion Date

July 10, 2023

Study Completion Date

July 17, 2023

Conditions

Healthy

Interventions

DRUG

Reference Drug or Test Drug

Tablet, Oral, QD for 1 Day, Washout period is more than 21 days after administration

Trial Locations (1)

Unknown

Clinical Trial Center, Jeonbuk National University Hospital, Jeonju

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY